Monica Brady's most recent trade in ProPhase Labs Inc was a trade of 25,000 Option (right to buy) done . Disclosure was reported to the exchange on May 23, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ProPhase Labs Inc | Monica Brady | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 25,000 | 0 | - | - | Option (right to buy) | |
| ProPhase Labs Inc | Monica Brady | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.15 per share. | 23 May 2022 | 25,000 | 32,428 (0%) | 0% | 2.2 | 53,750 | Common Stock, par value $0.0005 |
| ProPhase Labs Inc | Monica Brady | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 14,250 | 35,750 | - | - | Option (right to buy) | |
| ProPhase Labs Inc | Monica Brady | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.18 per share. | 23 May 2022 | 14,250 | 46,678 (0%) | 0% | 3.2 | 45,315 | Common Stock, par value $0.0005 |
| ProPhase Labs Inc | Monica Brady | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.47 per share. | 23 May 2022 | 11,806 | 34,872 (0%) | 0% | 8.5 | 99,997 | Common Stock, par value $0.0005 |
| ProPhase Labs Inc | Monica Brady | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2020 | 150,000 | 150,000 | - | - | Option (right to buy) |